Real-time enrollment status for this phelan-mcdermid syndrome clinical trial
Current Status
Recruiting
Checked: October 13, 2026 at 2:21 PM UTC
| NCT Number | NCT07281079 |
| Recruiting Status | Recruiting |
| Condition | Phelan-McDermid Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 160 participants |
| Active Locations | 17 sites in the US |
| Sponsor | Neuren Pharmaceuticals Limited |
| Last Updated on CT.gov | September 28, 2026 (2 weeks ago) |
As of October 13, 2026: Clinical trial NCT07281079 is currently recruiting participants. This phase3 study for phelan-mcdermid syndrome is actively seeking new participants at 17 locations across the United States. The study is sponsored by Neuren Pharmaceuticals Limited. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07281079 is actively recruiting participants as of October 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 17 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07281079 was last updated 2 weeks ago (September 28, 2026). HelloStudys verifies this status automatically.